Breast cancer is a complex heterogeneous disease that is clinicopathologically classified into hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2) positive, and triple-negative breast cancer (TNBC) subtypes. This evidence concerns the gene ERBB2 and breast cancer.